PubMed

Adrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.

Pacanowski MA, Zineh I, Li H, Johnson BD, Cooper-DeHoff RM, Bittner V, McNamara DM, Sharaf BL, Merz CN, Pepine CJ, Johnson JA.

J Transl Med. 2008 Mar 10;6:11.PMID: 18331634 [PubMed - indexed for MEDLINE]Related articlesFree article

beta-adrenergic receptor gene polymorphisms and beta-blocker treatment outcomes in hypertension.

Pacanowski MA, Gong Y, Cooper-Dehoff RM, Schork NJ, Shriver MD, Langaee TY, Pepine CJ, Johnson JA; INVEST Investigators.

Clin Pharmacol Ther. 2008 Dec;84(6):715-21. Epub 2008 Jul 9.PMID: 18615004 [PubMed - indexed for MEDLINE]Related articlesFree article

Association of beta1-adrenergic receptor genetic polymorphism with mental stress-induced myocardial ischemia in patients with coronary artery disease.

Hassan M, York KM, Li H, Li Q, Gong Y, Langaee TY, Fillingim RB, Johnson JA, Sheps DS.

Arch Intern Med. 2008 Apr 14;168(7):763-70.PMID: 18413560 [PubMed - indexed for MEDLINE]Related articlesFree article

Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women.

Wessel TR, Arant CB, Olson MB, Johnson BD, Reis SE, Sharaf BL, Shaw LJ, Handberg E, Sopko G, Kelsey SF, Pepine CJ, Merz NB.

JAMA. 2004 Sep 8;292(10):1179-87.PMID: 15353530 [PubMed - indexed for MEDLINE]Related articlesFree article

Association between beta-adrenergic receptor polymorphisms and their G-protein-coupled receptors with body mass index and obesity in women: a report from the NHLBI-sponsored WISE study.

Terra SG, McGorray SP, Wu R, McNamara DM, Cavallari LH, Walker JR, Wallace MR, Johnson BD, Bairey Merz CN, Sopko G, Pepine CJ, Johnson JA.

Int J Obes (Lond). 2005 Jul;29(7):746-54.PMID: 15917856 [PubMed - indexed for MEDLINE]Related articles

Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome.

Lanfear DE, Jones PG, Marsh S, Cresci S, McLeod HL, Spertus JA.

JAMA. 2005 Sep 28;294(12):1526-33.PMID: 16189366 [PubMed - indexed for MEDLINE]Related articlesFree article

Depression symptom severity and reported treatment history in the prediction of cardiac risk in women with suspected myocardial ischemia: The NHLBI-sponsored WISE study.

Rutledge T, Reis SE, Olson MB, Owens J, Kelsey SF, Pepine CJ, Mankad S, Rogers WJ, Merz CN, Sopko G, Cornell CE, Sharaf B, Matthews KA, Vaccarino V.

Arch Gen Psychiatry. 2006 Aug;63(8):874-80.PMID: 16894063 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study.

Kip KE, Marroquin OC, Kelley DE, Johnson BD, Kelsey SF, Shaw LJ, Rogers WJ, Reis SE.

Circulation. 2004 Feb 17;109(6):706-13.PMID: 14970104 [PubMed - indexed for MEDLINE]Related articlesFree article

Multiple interactions between the alpha 2C- and beta1-adrenergic receptors influence heart failure survival.

Kardia SL, Kelly RJ, Keddache MA, Aronow BJ, Grabowski GA, Hahn HS, Case KL, Wagoner LE, Dorn GW 2nd, Liggett SB.

BMC Med Genet. 2008 Oct 23;9:93.PMID: 18947427 [PubMed - indexed for MEDLINE]Related articlesFree article

Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease: results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE).

Johnson BD, Shaw LJ, Buchthal SD, Bairey Merz CN, Kim HW, Scott KN, Doyle M, Olson MB, Pepine CJ, den Hollander J, Sharaf B, Rogers WJ, Mankad S, Forder JR, Kelsey SF, Pohost GM; National Institutes of Health-National Heart, Lung, and Blood Institute.

Circulation. 2004 Jun 22;109(24):2993-9. Epub 2004 Jun 14.PMID: 15197152 [PubMed - indexed for MEDLINE]Related articlesFree article

Importance of socioeconomic status as a predictor of cardiovascular outcome and costs of care in women with suspected myocardial ischemia. Results from the National Institutes of Health, National Heart, Lung and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE).

Shaw LJ, Merz CN, Bittner V, Kip K, Johnson BD, Reis SE, Kelsey SF, Olson M, Mankad S, Sharaf BL, Rogers WJ, Pohost GM, Sopko G, Pepine CJ; WISE Investigators.

J Womens Health (Larchmt). 2008 Sep;17(7):1081-92.PMID: 18774893 [PubMed - indexed for MEDLINE]Related articlesFree article

Association of beta-1 and beta-2 adrenergic receptor gene polymorphisms with myocardial infarction.

Yilmaz A, Kaya MG, Merdanoglu U, Ergun MA, Cengel A, Menevse S.

J Clin Lab Anal. 2009;23(4):237-43.PMID: 19623647 [PubMed - indexed for MEDLINE]Related articles

Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: a report from the Women's Ischemia Syndrome Evaluation.

Marroquin OC, Kip KE, Kelley DE, Johnson BD, Shaw LJ, Bairey Merz CN, Sharaf BL, Pepine CJ, Sopko G, Reis SE; Women's Ischemia Syndrome Evaluation Investigators.

Circulation. 2004 Feb 17;109(6):714-21.PMID: 14970105 [PubMed - indexed for MEDLINE]Related articlesFree article

Depressive symptom dimensions and cardiovascular prognosis among women with suspected myocardial ischemia: A report from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation.

Linke SE, Rutledge T, Johnson BD, Vaccarino V, Bittner V, Cornell CE, Eteiba W, Sheps DS, Krantz DS, Parashar S, Bairey Merz CN.

Arch Gen Psychiatry. 2009 May;66(5):499-507.PMID: 19414709 [PubMed - indexed for MEDLINE]Related articlesFree article

GLU-27 variant of beta2-adrenergic receptor polymorphisms is an independent risk factor for coronary atherosclerotic disease.

Barbato E, Berger A, Delrue L, Van Durme F, Manoharan G, Boussy T, Heyndrickx GR, De Bruyne B, Ciampi Q, Vanderheyden M, Wijns W, Bartunek J.

Atherosclerosis. 2007 Oct;194(2):e80-6. Epub 2006 Nov 13.PMID: 17094995 [PubMed - indexed for MEDLINE]Related articles

Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol.

Sehnert AJ, Daniels SE, Elashoff M, Wingrove JA, Burrow CR, Horne B, Muhlestein JB, Donahue M, Liggett SB, Anderson JL, Kraus WE.

J Am Coll Cardiol. 2008 Aug 19;52(8):644-51. Epub 2008 Jun 23.PMID: 18702968 [PubMed - indexed for MEDLINE]Related articles

Hostility scores are associated with increased risk of cardiovascular events in women undergoing coronary angiography: a report from the NHLBI-Sponsored WISE Study.

Olson MB, Krantz DS, Kelsey SF, Pepine CJ, Sopko G, Handberg E, Rogers WJ, Gierach GL, McClure CK, Merz CN; WISE Study Group.

Psychosom Med. 2005 Jul-Aug;67(4):546-52.PMID: 16046366 [PubMed - indexed for MEDLINE]Related articlesFree article

Association between polymorphisms in the beta2-adrenergic receptor gene with myocardial infarction and ischaemic stroke in women.

Schürks M, Kurth T, Ridker PM, Buring JE, Zee RY.

Thromb Haemost. 2009 Feb;101(2):351-8.PMID: 19190821 [PubMed - indexed for MEDLINE]Related articlesFree article

Adrenergic receptor genotype but not perioperative bisoprolol therapy may determine cardiovascular outcome in at-risk patients undergoing surgery with spinal block: the Swiss Beta Blocker in Spinal Anesthesia (BBSA) study: a double-blinded, placebo-controlled, multicenter trial with 1-year follow-up.

Zaugg M, Bestmann L, Wacker J, Lucchinetti E, Boltres A, Schulz C, Hersberger M, Kälin G, Furrer L, Hofer C, Blumenthal S, Müller A, Zollinger A, Spahn DR, Borgeat A.

Anesthesiology. 2007 Jul;107(1):33-44.PMID: 17585213 [PubMed - indexed for MEDLINE]Related articlesFree article

[Interactions between beta1 and beta2 adrenergic receptor polymorphisms as risk factors for chronic heart failure]

Moraga F, Troncoso R, Mellado R, Díaz-Araya G, Vukasovic JL, Greig D, Perez O, García L, Roldán J, Ocaranza MP, Jali J, Chiong M, Castro P.

Rev Med Chil. 2008 Nov;136(11):1371-80. Spanish. PMID: 19301767 [PubMed - indexed for MEDLINE]Related articles